Chuangmei Pharmaceutical

I: Investor Relations

Announcements and Circulars

The current position: Home>Investor Relations>Announcements and Circulars

Year

2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

252017-04

NOTICE OF ANNUAL GENERAL MEETING
252017-04

(1) CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING; (2) AMENDMENTS TO THE ARTICLES OF ASSOCIATION; (3) PROPOSALS FOR PROFIT DISTRIBUTION PLAN AND DECLARATION OF FINAL DIVIDENDS FOR THE YEAR 2016; (4) PROPOSAL FOR CHANGE OF AUDITORS; AND (5) NOTICE OF ANNUAL GENERAL MEETING
252017-04

2016 Annual Report
132017-04

CHANGE OF THE DATE OF ANNUAL GENERAL MEETING AND CHANGE OF THE PERIOD FOR CLOSURE OF THE REGISTER OF MEMBERS;(2) PROPOSAL FOR CHANGE OF AUDITORS;AND (3) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
052017-04

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2017
222017-03

Other - Business Update-PROPOSED CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING
222017-03

Final Results / Dividend or Distribution / Closure of Books or Change of Book Closure Period - ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2016
132017-03

Voluntary Announcement Investment in Zhuhai Hengxiang Pharmaceutical Limited
092017-03

Date of Board Meeting -Notice of Board Meeting
012017-03

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2017
022017-02

Monthly Returns - Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2017
242017-01

Profit Warning / Inside Information

2 3 4 5 6

The Enterprise OA